An IVC filter is a tiny metal device that is designed to stop a blood clot from making its way to a patient’s lungs. Resembling a metal cage, doctors surgically insert this device into a patient’s inferior vena cava (IVC), which is the vein that transports blood to the heart and lungs. This device is commonly used in patients with an increased risk of blood clots and for those who are not good candidates for blood thinners. While these devices can save lives, they can also cause serious health complications.
Reported issues with retrievable IVC filters include:
Some of these adverse events are linked to how long the filter has been implanted. The FDA has reported concerns regarding the risks of retrievable IVC filters, citing high device failure rates, fractures, migrations, and organ perforation. Countless individuals have already suffered harm or death from the devices, leading to lawsuits across the country.
The first lawsuit was filed in 2012 against C.R. Bard in California and Pennsylvania state courts. Since then, the number of lawsuits involving IVC filters by Cook Medical and C.R. Bard has increased to more than 100 in state and federal courts. In August 2015, the U.S. Judicial Panel on Multi District Litigation consolidated lawsuits against C.R. Bard in the U.S. District Court District of Arizona. More than 50 lawsuits are pending in the MDL.
The various lawsuits claim manufacturer negligence, design defects, misrepresentation, and failure to warn of the risks despite knowledge of them.
Products known to cause dangerous health problems include:
Kaiser Gornick LLP is at the forefront of product liability litigation in the United States. One of our experienced lawyers can help you seek compensation for your losses and hold manufacturers responsible for their negligence. We have successfully negotiated and litigated complex claims against some of the largest pharmaceutical companies. Our law firm has the financial resources and manpower necessary to handle claims of any scale and scope.
We accept cases on a contingency fee basis.